FTC evaluates competition in biologic medicines

(February 17, 2014) -- FTC Chairwoman Edith Ramirez kicked off a recent agency workshop by talking about the life-saving properties of biologic medicines in providing therapies for difficult to treat diseases, ranging from cancer to diabetes to multiple sclerosis. But she also pointed to their very high price tags....

Related Sections